Tokinolide B
CAS: 112966-16-2
Ref. 3D-MEA96616
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
- (1′S,3Z,3aS,5R,6R)-3-Butylidene-5,6,6′,7′-tetrahydro-5-propylspiro[3H-3a,6-ethanoisobenzofuran-4(1H),1′(3′H)-isobenzofuran]-1,3′-dione
- (3'Z)-(3S,8R,3a'S,6'R)-3,3a':8,6'-Diligustilide
- (3′Z)-(3S,8R,3a'S,6′R)-3,3a′:8,6′-Diligustilide
- Spiro[3H-3a,6-ethanoisobenzofuran-4(1H),1'(3'H)-isobenzofuran]-1,3'-dione,3-butylidene-5,6,6',7'-tetrahydro-5-propyl-, [3aS-(3Z,3aa,4a,5a,6a)]-
- Spiro[3H-3a,6-ethanoisobenzofuran-4(1H),1′(3′H)-isobenzofuran]-1,3′-dione, 3-butylidene-5,6,6′,7′-tetrahydro-5-propyl-, (1′S,3Z,3aS,5R,6R)-
- Spiro[3H-3a,6-ethanoisobenzofuran-4(1H),1′(3′H)-isobenzofuran]-1,3′-dione, 3-butylidene-5,6,6′,7′-tetrahydro-5-propyl-, [3aS-(3Z,3aα,4α,5α,6α)]-
Tokinolide B is a dietary supplement that is used to treat various nervous system and inflammatory diseases. This agent has been shown to inhibit the activity of the progesterone receptor, which may be due to its inhibition of fatty acid synthesis. Tokinolide B also inhibits the activity of the ligustilide-sensitive receptor, which is responsible for the transmission of nerve impulses. The biological properties of this drug have been shown in studies on humans, where it was shown to have an inhibitory effect on fatty acids and organic acids.
Chemical properties
Technical inquiry about: 3D-MEA96616 Tokinolide B
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
